Related Experiment Video
Updated: Aug 16, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Nucleotide analogs as novel anti-hepatitis B virus agents
Radhakrishnan P Iyer1, Seetharamaiyer Padmanabhan, Guangrong Zhang
1Spring Bank Technologies Inc, Milford, MA 01757, USA. kiyer@springbanktech.com
Abstract:
During the past decade, nucleotide analogs have emerged as novel antiviral agents against hepatitis B virus. Adefovir dipivoxil, a prototype phosphonate analog, has been approved for chronic hepatitis B virus therapy, and additional phosphonate analogs and di- and tri-nucleotides are under development. Several innovative prodrug derivatizations have also been reported to improve the oral bioavailability of nucleotide analogs, which usually carry a negative charge.
Related Concept Videos
Antiviral Nucleoside Inhibitors
DNA Base Pairing
Hepatitis
Inhibitors Of Virion Release
Inhibitors of Viral Protein Synthesis
Viruses with RNA Genomes
